Tissue Characterization in STEMI Using Cardiac MRI: a Multicenter Registry

This multicenter registry includes patients with a first ST-segment elevation myocardial infarction (STEMI) who underwent cardiac magnetic resonance (CMR) imaging during the acute phase and follow-up. The registry is designed to identify clinical and CMR-derived predictors of adverse ventricular remodeling and major adverse cardiac events (MACE). CMR provides accurate and reproducible assessment of infarct size, left ventricular function, microvascular obstruction, and tissue characteristics, enabling detailed prognostic modeling.

NCT Number	NCT07291999
Lead Sponsor	Fundación para la Investigación del Hospital Clínico de Valencia Collaborators: Hospital Clinic of Barcelona, Hospital Vall d'Hebron
Conditions	Ischemic Cardiovascular Disease, Magnetic Resonance
Enrollment	500 participants
Start Date	2025-01-01
Primary Completion	2025-09-30 (estimated)
Study Completion	2036-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-12-18